Sort
11,323 grants matching “glioblastoma”
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
$293,550Gregory E Plautz · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · CA
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
$293,550Gregory E Plautz · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma
$293,282Alexander H. Stegh · Northwestern University At Chicago · P50 · FY2022 · CA
Molecular mechanisms of TRAIL resistance in glioblastoma
$293,258Chunhai Charlie Hao · Emory University · R01 · FY2013 · CA
Cas Protein Regulation of EMT in Cancer
$293,155Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2011 · CA
Core C: Subtractive Single Nucleus Seq and Spatial Multi-omics Core
$293,125Le Zhang · Yale University · P01 · FY2024 · AI
Core C: Subtractive Single Nucleus Seq and Spatial Multi-omics Core
$293,125Le Zhang · Yale University · P01 · FY2023 · AI
Core C: Subtractive Single Nucleus Seq and Spatial Multi-omics Core
$293,125Le Zhang · Yale University · P01 · FY2025 · AI
An Acceptance and Commitment Therapy-Based Psychosocial Intervention to Alleviate Distress and Promote Adaptive Coping Skills in Patients with Malignant Primary Central Nervous System Tumors
$293,053Deborah A Forst · Massachusetts General Hospital · K08 · FY2024 · CA
An Acceptance and Commitment Therapy-Based Psychosocial Intervention to Alleviate Distress and Promote Adaptive Coping Skills in Patients with Malignant Primary Central Nervous System Tumors
$293,053Deborah A Forst · Massachusetts General Hospital · K08 · FY2025 · CA
10Q TUMOR SUPPRESSOR GENE
$293,026University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma
$292,895Deliang Guo · Ohio State University · R01 · FY2022 · CA
Elucidating the Function of the NF1 tumor suppressor and its effector pathways in
$292,751Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2010 · CA
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS
$292,637Massachusetts General Hospital · R01 · FY2003 · CA
Predictive Markers of Glioblastoma Response to VEGF Trap
$292,600John F De Groot · University Of Tx Md Anderson Can Ctr · R21 · FY2007 · CA
Predictive Markers of Glioblastoma Response to VEGF Trap
$292,600John F De Groot · University Of Tx Md Anderson Can Ctr · R21 · FY2008 · CA
Oligonucleotide Synthesis & NanoConstructs Core
$292,518Teri Wang Odom · Northwestern University At Chicago · U54 · FY2015 · CA
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures
$292,500Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2020 · AG
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
$292,312Russell O Pieper · University Of California, San Francisco · R01 · FY2013 · CA
OSU-03012 therapy for glioblastoma
$292,282Paul Dent · Virginia Commonwealth University · R01 · FY2014 · CA
Cas Protein Regulation of EMT in Cancer
$292,099Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2007 · CA
Using Insights from EGFRvIII to Improve EGFR Directed Therapy in Human Gliomas
$292,056Albert J. Wong · Stanford University · R01 · FY2011 · CA
Temodar Resistance in CNS Tumors
$292,039Henry S. Friedman · Duke University · R01 · FY2007 · NS
Temodar Resistance in CNS Tumors
$292,039Henry S. Friedman · Duke University · R01 · FY2008 · NS
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
$292,015Robert W Sobol · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA